Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 2106465, 25 pages
http://dx.doi.org/10.1155/2016/2106465
Research Article

Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes

1Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
2Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation, 11800 Penang, Malaysia
3Department of Pharmacology and Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia
4Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, SP 8, 09042 Monserrato, Italy
5School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 9 Heroon Polytechniou Street, 15780 Athens, Greece
6School of Information Management, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
7Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK

Received 14 September 2015; Accepted 3 December 2015

Academic Editor: Jae Youl Cho

Copyright © 2016 Siti Zuraidah Mohamad Zobir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Chan, “Progress in traditional Chinese medicine,” Trends in Pharmacological Sciences, vol. 16, no. 6, pp. 182–187, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Waldram, “The efficacy of traditional medicine: current theoretical and methodological issues,” Medical Anthropology Quarterly, vol. 14, no. 4, pp. 603–625, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Chen and H. Xu, “The integration of traditional Chinese medicine and Western medicine,” European Review, vol. 11, no. 2, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Chan, M. Tan, J. Xin, S. Sudarsanam, and D. E. Johnson, “Interactions between traditional Chinese medicines and Western therapeutics,” Current Opinion in Drug Discovery & Development, vol. 13, no. 1, pp. 50–65, 2010. View at Google Scholar · View at Scopus
  5. Y. Wang and A. Xu, “Zheng: a systems biology approach to diagnosis and treatments,” Science, vol. 346, no. 6216, pp. S13–S15, 2014. View at Google Scholar
  6. X. Zhao, X. Zheng, T.-P. Fan, Z. Li, Y. Zhang, and J. Zheng, “A novel drug discovery strategy inspired by traditional medicine philosophies,” Science, vol. 347, no. 6219, pp. S38–S40, 2015. View at Google Scholar
  7. R. H. Liu, R. S. Runyon, Y. C. Wang, S. G. Oliver, T.-P. Fan, and W. D. Zhang, “Deciphering ancient combinatorial formulas: the Shexiang Baoxin pill,” Science, vol. 347, no. 6219, pp. S40–S42, 2015. View at Google Scholar
  8. W. Lam, S.-H. Liu, Z. Jiang, and Y.-C. Cheng, “Lessons from the development of the traditional Chinese medicine formula PHY906,” Science, vol. 347, no. 6219, pp. S43–S44, 2015. View at Google Scholar
  9. H. Sheridan, B. Kopp, L. Krenn, D. Guo, and J. Sendker, “Traditional Chinese herbal medicine preparation: invoking the butterfly effect,” Science, vol. 350, no. 6262, pp. S64–S66, 2015. View at Google Scholar
  10. S. Li, “Mapping ancient remedies: applying a network approach to traditional Chinese medicine,” Science, vol. 350, no. 6262, pp. S72–S74, 2015. View at Google Scholar
  11. B. He, C. Lu, M. Wang et al., “Drug discovery in traditional Chinese medicine: from herbal fufang to combinatory drugs,” Science, vol. 350, no. 6262, pp. S74–S76, 2015. View at Google Scholar
  12. J. K. Chen and T. T. Chen, Chinese Medical Herbalogy and Pharmacology, Art of Medicine Press, Industry, Calif, USA, 2004.
  13. C. Y. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar
  14. J. Zhao, P. Jiang, and W. Zhang, “Molecular networks for the study of TCM pharmacology,” Briefings in Bioinformatics, vol. 11, no. 4, pp. 417–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Zhao, Q. Zhou, W. Ma, and D.-Q. Wei, “Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 806072, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Qiu, “A culture in the balance,” Nature, vol. 448, no. 7150, pp. 126–128, 2007. View at Publisher · View at Google Scholar
  17. L. Wang, G.-B. Zhou, P. Liu et al., “Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 12, pp. 4826–4831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T.-P. Fan, J.-C. Yeh, K. W. Leung, P. Y. K. Yue, and R. N. S. Wong, “Angiogenesis: from plants to blood vessels,” Trends in Pharmacological Sciences, vol. 27, no. 6, pp. 297–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ma, C. Feng, X. Zhang et al., “The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology,” Complementary Therapies in Medicine, vol. 21, no. 1, pp. 35–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Xu, “Modernization: one step at a time,” Nature, vol. 480, no. 7378, pp. S90–S92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. W. Corson and C. M. Crews, “Molecular understanding and modern application of traditional medicines: triumphs and trials,” Cell, vol. 130, no. 5, pp. 769–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Cai, Q. Luo, M. Sun, and H. Corke, “Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer,” Life Sciences, vol. 74, no. 17, pp. 2157–2184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Wang, H. Kuang, Y. Su et al., “Naturally derived anti-inflammatory compounds from Chinese medicinal plants,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 9–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. J. Kang, “Herbogenomics: from traditional Chinese medicine to novel therapeutics,” Experimental Biology and Medicine, vol. 233, no. 9, pp. 1059–1065, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Birchall, V. J. Gillet, G. Harper, and S. D. Pickett, “Training similarity measures for specific activities: application to reduced graphs,” Journal of Chemical Information and Modeling, vol. 46, no. 2, pp. 577–586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. F. Fliri, W. T. Loging, P. F. Thadeio, and R. A. Volkmann, “Biological spectra analysis: linking biological activity profiles to molecular structure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 2, pp. 261–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Klekota, E. Brauner, F. P. Roth, and S. L. Schreiber, “Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects,” Journal of Chemical Information and Modeling, vol. 46, no. 4, pp. 1549–1562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Nidhi, M. Glick, J. W. Davies, and J. L. Jenkins, “Prediction of biological targets for compounds using multiple-category bayesian models trained on chemogenomics databases,” Journal of Chemical Information and Modeling, vol. 46, no. 3, pp. 1124–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, “PASS: prediction of activity spectra for biologically active substances,” Bioinformatics, vol. 16, no. 8, pp. 747–748, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Bender, D. W. Young, J. L. Jenkins et al., “Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprints,” Combinatorial Chemistry & High Throughput Screening, vol. 10, no. 8, pp. 719–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Paul, E. Kellenberger, G. Bret, P. Müller, and D. Rognan, “Recovering the true targets of specific ligands by virtual screening of the protein data bank,” Proteins: Structure, Function and Genetics, vol. 54, no. 4, pp. 671–680, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Chen, C. Y. Ung, and Y. Chen, “Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients?” Natural Product Reports, vol. 20, no. 4, pp. 432–444, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. T. M. Ehrman, D. J. Barlow, and P. J. Hylands, “In silico search for multi-target anti-inflammatories in Chinese herbs and formulas,” Bioorganic & Medicinal Chemistry, vol. 18, no. 6, pp. 2204–2218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Zhang, W. Lu, X. Liu et al., “Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach,” Medicinal Chemistry Communication, vol. 2, no. 6, pp. 471–477, 2011. View at Publisher · View at Google Scholar
  35. J. L. Jenkins, A. Bender, and J. W. Davies, “In silico target fishing: predicting biological targets from chemical structure,” Drug Discovery Today: Technologies, vol. 3, no. 4, pp. 413–421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Xu and A. Hagler, “Chemoinformatics and drug discovery,” Molecules, vol. 7, no. 8, pp. 566–600, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Willett, J. M. Barnard, and G. M. Downs, “Chemical similarity searching,” Journal of Chemical Information and Computer Sciences, vol. 38, no. 6, pp. 983–996, 1998. View at Google Scholar · View at Scopus
  38. A. Koutsoukas, B. Simms, J. Kirchmair et al., “From in silico target prediction to multi-target drug design: current databases, methods and applications,” Journal of Proteomics, vol. 74, no. 12, pp. 2554–2574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Poroikov, D. Filimonov, A. Lagunin, T. Gloriozova, and A. Zakharov, “PASS: identification of probable targets and mechanisms of toxicity,” SAR and QSAR in Environmental Research, vol. 18, no. 1-2, pp. 101–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Keiser, B. L. Roth, B. N. Armbruster, P. Ernsberger, J. J. Irwin, and B. K. Shoichet, “Relating protein pharmacology by ligand chemistry,” Nature Biotechnology, vol. 25, no. 2, pp. 197–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Yu, J. Chen, X. Xu et al., “A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data,” PLoS ONE, vol. 7, no. 5, Article ID e37608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Li, X. Xu, X. Wang et al., “A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 13501–13520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Li, W. Tao, C. Zheng et al., “Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: an example using Xiao-Chaihu-Decoction and Da-Chaihu-Decoction,” Computers in Biology and Medicine, vol. 53, pp. 19–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Mohd Fauzi, A. Koutsoukas, R. Lowe et al., “Chemogenomics approaches to rationalizing the mode-of-action of traditional chinese and ayurvedic medicines,” Journal of Chemical Information and Modeling, vol. 53, no. 3, pp. 661–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kanehisa and S. Goto, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. A. A. Lagunin, R. K. Goel, D. Y. Gawande et al., “Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review,” Natural Product Reports, vol. 31, no. 11, pp. 1585–1611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. Molecular Operating Environemnt (MOE), Chemical Computing Group, Montreal, Canada, 2010.
  48. A. Koutsoukas, R. Lowe, Y. Kalantar-Motamedi et al., “In silico target predictions: comparing multiclass Naïve Bayes and Parzen-Rosenblatt Window and the definition of a benchmarking dataset for target prediction,” Journal of Chemical Information and Modeling, vol. 53, no. 8, pp. 1957–1966, 2013. View at Google Scholar
  49. A. Gaulton, L. J. Bellis, A. P. Bento et al., “ChEMBL: a large-scale bioactivity database for drug discovery,” Nucleic Acids Research, vol. 40, no. 1, pp. D1100–D1107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Bender, H. Y. Mussa, R. C. Glen, and S. Reiling, “Similarity searching of chemical databases using atom environment descriptors (MOLPRINT 2D): evaluation of performance,” Journal of Chemical Information and Computer Sciences, vol. 44, no. 5, pp. 1708–1718, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. A. Flach and N. Lachiche, “Naive Bayesian classification of structured data,” Machine Learning, vol. 57, no. 3, pp. 233–269, 2004. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  52. M. Olah, R. Rad, L. Ostopovici et al., “WOMBAT and WOMBAT-PK: bioactivity databases for lead and drug discovery,” in Chemical Biology, chapter 13, pp. 760–786, Wiley-VCH, Weinheim, Germany, 2007. View at Publisher · View at Google Scholar
  53. G. Drakakis, A. Koutsoukas, S. Brewerton, M. Bodkin, D. Evans, and A. Bender, “Comparing global and local likelihood score thresholds in multiclass laplacian-modified naive bayes protein target prediction,” Combinatorial Chemistry & High Throughput Screening, vol. 18, no. 3, pp. 323–330, 2015. View at Publisher · View at Google Scholar
  54. M. Kanehisa, S. Goto, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “Data, information, knowledge and principle: back to metabolism in KEGG,” Nucleic Acids Research, vol. 42, no. 1, pp. D199–D205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Liggi, G. Drakakis, A. E. Hendry et al., “Extensions to in silico bioactivity predictions using pathway annotations and differential pharmacology analysis: application to Xenopus laevis phenotypic readouts,” Molecular Informatics, vol. 32, no. 11-12, pp. 1009–1024, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Liggi, G. Drakakis, A. Koutsoukas et al., “Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts,” Future Medicinal Chemistry, vol. 6, no. 18, pp. 2029–2056, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. E. E. Bolton, Y. Wang, P. A. Thiessen, and S. H. Bryant, “PubChem: integrated platform of small molecules and biological activities,” in Annual Reports in Computational Chemistry, vol. 4, chapter 12, pp. 217–241, Elsevier, Washington, DC, USA, 2008. View at Publisher · View at Google Scholar
  58. J. J. Irwin, T. Sterling, M. M. Mysinger, E. S. Bolstad, and R. G. Coleman, “ZINC: a free tool to discover chemistry for biology,” Journal of Chemical Information and Modeling, vol. 52, no. 7, pp. 1757–1768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. W. Liu and D. E. Johnson, “Clustering and its application in multi-target prediction,” Current Opinion in Drug Discovery & Development, vol. 12, no. 1, pp. 98–107, 2009. View at Google Scholar · View at Scopus
  60. R. D. Browne and Y. C. Martin, “Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection,” Journal of Chemical Information and Computer Sciences, vol. 36, no. 3, pp. 572–584, 1996. View at Publisher · View at Google Scholar
  61. RDC Team, RStudio: Integrated Development Environment for R, Rstudio, Boston, Mass, USA, 2010.
  62. J. H. Ward, “Hierarchical grouping to optimize an objective function,” Journal of the American Statistical Association, vol. 58, no. 301, pp. 236–244, 1963. View at Publisher · View at Google Scholar · View at MathSciNet
  63. The UniProt Consortium, “Activities at the universal protein resource (UniProt),” Nucleic Acids Research, vol. 42, no. 1, pp. D191–D198, 2014. View at Publisher · View at Google Scholar
  64. A. Bender and R. C. Glen, “Molecular similarity: a key technique in molecular informatics,” Organic and Biomolecular Chemistry, vol. 2, no. 22, pp. 3204–3218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Nussbaumer and A. Billich, “Steroid sulfatase inhibitors,” Medicinal Research Reviews, vol. 24, no. 4, pp. 529–576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. K. M. Doody, A. Bourdeau, and M. L. Tremblay, “T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease,” Immunological Reviews, vol. 228, no. 1, pp. 325–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. A. M. Cameron, J. Frederick, C. Nucifora, E. T. Fung et al., “FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain,” Journal of Biological Chemistry, vol. 272, no. 44, pp. 27582–27588, 1997. View at Publisher · View at Google Scholar
  68. S. A. Jabbour and B. J. Goldstein, “Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes,” International Journal of Clinical Practice, vol. 62, no. 8, pp. 1279–1284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. L. Nitiss, “Investigating the biological functions of DNA topoisomerases in eukaryotic cells,” Biochimica et Biophysica Acta (BBA)—Gene Structure and Expression, vol. 1400, no. 1–3, pp. 63–81, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Andersson, W. M. Geissler, L. Wu et al., “Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency,” The Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 1, pp. 130–136, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Bařinka, C. Rojas, B. Slusher, and M. Pomper, “Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer,” Current Medicinal Chemistry, vol. 19, no. 6, pp. 856–870, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. B. E. Shan, K. Zeki, T. Sugiura, Y. Yoshida, and U. Yamashita, “Chinese medicinal herb, Acanthopanax gracilistylus, extract induces cell cycle arrest of human tumor cells in vitro,” Japanese Journal of Cancer Research, vol. 91, no. 4, pp. 383–389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Zhang, A. S. Ravipati, S. R. Koyyalamudi et al., “Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds,” Journal of Agricultural and Food Chemistry, vol. 59, no. 23, pp. 12361–12367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. Chinese Herbal Medicine Materia Medica, Eastlan Press, Seattle, Wash, USA, 3rd edition, 2004.
  75. T. N. Hilton, L. J. Tuttle, K. L. Bohnert, M. J. Mueller, and D. R. Sinacore, “Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function,” Physical Therapy, vol. 88, no. 11, pp. 1336–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Giordano, M. Calvani, O. Petillo, M. Carteni, M. R. A. B. Melone, and G. Peluso, “Skeletal muscle metabolism in physiology and in cancer disease,” Journal of Cellular Biochemistry, vol. 90, no. 1, pp. 170–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Pouliot, S. Bergeron, A. Marette, and M. Olivier, “The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development,” Immunology, vol. 128, no. 4, pp. 534–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. A. B. Hocaoglu, O. Karaman, D. O. Erge et al., “Glycyrrhizin and long-term histopathologic changes in a murine model of asthma,” Current Therapeutic Research, vol. 72, no. 6, pp. 250–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. J. H. Choi, Y. P. Hwang, H. G. Kim et al., “Saponins from the roots of platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells,” Nutrition and Cancer, vol. 66, no. 1, pp. 140–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. S. R. Kim, H. S. Seo, H.-S. Choi et al., “Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 975350, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. X.-Q. Zhang, F. C. F. Ip, D.-M. Zhang et al., “Triterpenoids with neurotrophic activity from Ganoderma lucidum,” Natural Product Research, vol. 25, no. 17, pp. 1607–1613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Kawakami, Y. Kawakami, and J. Kitaura, “Protein kinase Cβ (PKCβ): nomal functions and dieases,” Journal of Biochemistry, vol. 132, no. 5, pp. 677–682, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Kashiwagi, M. Ohba, K. Chida, and T. Kuroki, “Protein kinase cη (PKCη): its involvement in keratinocyte differentiation,” Journal of Biochemistry, vol. 132, no. 6, pp. 853–857, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Saito and Y. Shirai, “Protein kinase Cγ (PKCγ): function of neuron specific isotype,” Journal of Biochemistry, vol. 132, no. 5, pp. 683–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Karodi, M. Jadhav, R. Rub, and A. Bafna, “Evaluation of the wound healing activity of a crude extract of Rubia cordifolia L. (Indian madder) in mice,” International Journal of Applied Research in Natural Products, vol. 2, no. 2, pp. 12–18, 2009. View at Google Scholar · View at Scopus
  86. L. Cao, Y. Zou, J. Zhu, X. Fan, and J. Li, “Ginsenoside Rg1 attenuates concanavalin A-induced hepatitis in mice through inhibition of cytokine secretion and lymphocyte infiltration,” Molecular and Cellular Biochemistry, vol. 380, no. 1-2, pp. 203–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. R. X. Zhang, Z. P. Jia, L. Y. Kong et al., “Stachyose extract from Rehmannia glutinosa Libosch. to lower plasma glucose in normal and diabetic rats by oral administration,” Pharmazie, vol. 59, no. 7, pp. 552–556, 2004. View at Google Scholar
  88. W. L. Li, H. C. Zheng, J. Bukuru, and N. De Kimpe, “Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. W. L. W. Hsiao and L. Liu, “The role of traditional Chinese herbal medicines in cancer therapy—from TCM theory to mechanistic insights,” Planta Medica, vol. 76, no. 11, pp. 1118–1131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. V. I. Polshakov, “Dihydrofolate reductase: structural aspects of mechanisms of enzyme catalysis and inhibition,” Russian Chemical Bulletin, vol. 50, no. 10, pp. 1733–1751, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. F.-M. Hsu, S. Zhang, and B. P. C. Chen, “Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment,” Translational Cancer Research, vol. 1, no. 1, pp. 22–34, 2012. View at Publisher · View at Google Scholar
  92. P. E. Wakefield, W. D. James, C. P. Samlaska, and M. S. Meltzer, “Tumor necrosis factor,” Journal of the American Academy of Dermatology, vol. 24, no. 5, pp. 675–685, 1991. View at Publisher · View at Google Scholar · View at Scopus
  93. W.-M. Chu, “Tumor necrosis factor,” Cancer Letters, vol. 328, no. 2, pp. 222–225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Adetumbi, G. T. Javor, and B. H. S. Lau, “Allium sativum (garlic) inhibits lipid synthesis by Candida albicans,” Antimicrobial Agents and Chemotherapy, vol. 30, no. 3, pp. 499–501, 1986. View at Publisher · View at Google Scholar · View at Scopus
  95. H.-D. Ma, Y.-R. Deng, Z. Tian, and Z.-X. Lian, “Traditional Chinese medicine and immune regulation,” Clinical Reviews in Allergy and Immunology, vol. 44, no. 3, pp. 229–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. S.-L. Tan and P. J. Parker, “Emerging and diverse roles of protein kinase C in immune cell signalling,” Biochemical Journal, vol. 376, no. 3, pp. 545–552, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. R. P. Heaney and C. M. Weaver, “Newer perspectives on calcium nutrition and bone quality,” Journal of the American College of Nutrition, vol. 24, no. 6, pp. 574S–581S, 2005. View at Google Scholar · View at Scopus
  98. M. Bielohuby, M. Matsuura, N. Herbach et al., “Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats,” Journal of Bone and Mineral Research, vol. 25, no. 2, pp. 275–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. R. E. Mebius and G. Kraal, “Structure and function of the spleen,” Nature Reviews Immunology, vol. 5, no. 8, pp. 606–616, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Dharmananda, “The Qi Keeps the Blood Within the Vessels,” 1998, http://www.itmonline.org/arts/guipitang.htm.
  101. F. Zhang, N. K. Altorki, Y.-C. Wu, R. A. Soslow, K. Subbaramaiah, and A. J. Dannenberg, “Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids,” Gastroenterology, vol. 121, no. 6, pp. 1391–1399, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. D.-W. Perng, K.-T. Chang, K.-C. Su et al., “Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-α1 production and fibroblast proliferation,” Chest, vol. 132, no. 5, pp. 1548–1556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. C.-H. Guo, P.-J. Liu, S. Hsia, C.-J. Chuang, and P.-C. Chen, “Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients,” Annals of Clinical Biochemistry, vol. 48, no. 4, pp. 344–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. W. Morse, “TCM Treatment of Bronchiol Asthma in Clinical Practice,” http://www.acupuncture.com/newsletters/m_feb08/TCM and Asthma.htm.
  105. N. C. Bishop, G. J. Walker, M. Gleeson, F. A. Wallace, and C. R. A. Hewitt, “Human T lymphocyte migration towards the supernatants of human rhinovirus infected airway epithelial cells: influence of exercise and carbohydrate intake,” Exercise Immunology Review, vol. 15, pp. 127–144, 2009. View at Google Scholar · View at Scopus
  106. M. P. Rayman, “The importance of selenium to human health,” The Lancet, vol. 356, no. 9225, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Orth and S. Bellosta, “Cholesterol: its regulation and role in central nervous system disorders,” Cholesterol, vol. 2012, Article ID 292598, 19 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Lim, M. Levy, and T. M. Bray, “Dietary zinc alters early inflammatory responses during cutaneous wound healing in weanling CD-1 mice,” The Journal of Nutrition, vol. 134, no. 4, pp. 811–816, 2004. View at Google Scholar · View at Scopus
  109. Y.-J. Shiao, J.-C. Chen, C.-N. Wang, and C.-T. Wang, “The mode of action of primary bile salts on human platelets,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1146, no. 2, pp. 282–293, 1993. View at Publisher · View at Google Scholar · View at Scopus
  110. R. K. Rao and G. Samak, “Bile duct epithelial tight junctions and barrier function,” Tissue Barriers, vol. 1, no. 4, Article ID e25718, 2013. View at Publisher · View at Google Scholar
  111. D. P. Chaudhary, R. Sharma, and D. D. Bansal, “Implications of magnesium deficiency in type 2 diabetes: a review,” Biological Trace Element Research, vol. 134, no. 2, pp. 119–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. J. Guo, H. Chen, J. Song, J. Wang, L. Zhao, and X. Tong, “Syndrome differentiation of diabetes by the traditional Chinese medicine according to evidence-based medicine and expert consensus opinion,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 492193, 7 pages, 2014. View at Publisher · View at Google Scholar
  113. J. F. Oram and A. M. Vaughan, “ATP-binding cassette cholesterol transporters and cardiovascular disease,” Circulation Research, vol. 99, no. 10, pp. 1031–1043, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Blanc, W. Y. Hsieh, K. A. Robertson et al., “Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis,” PLoS Biology, vol. 9, no. 3, Article ID e1000598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. J. L. Wylie, G. M. Hatch, and G. Mcclarty, “Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis,” Journal of Bacteriology, vol. 179, no. 23, pp. 7233–7242, 1997. View at Google Scholar · View at Scopus
  116. D. W. Good, T. George, and B. A. Watts III, “Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes,” American Journal of Physiology—Renal Physiology, vol. 297, no. 4, pp. F866–F874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Cuenda and S. Rousseau, “p38 MAP-kinases pathway regulation, function and role in human diseases,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1773, no. 8, pp. 1358–1375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Li and P. Agarwal, “A pathway-based view of human diseases and disease relationships,” PLoS ONE, vol. 4, no. 2, Article ID e4346, 2009. View at Publisher · View at Google Scholar
  119. G. Manning, D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, “The protein kinase complement of the human genome,” Science, vol. 298, no. 5600, pp. 1912–1934, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. K. L. Pierce, R. T. Premont, and R. J. Lefkowitz, “Seven-transmembrane receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 639–650, 2002. View at Publisher · View at Google Scholar
  121. T. M. Ehrman, D. J. Barlow, and P. J. Hylands, “Phytochemical informatics of traditional Chinese medicine and therapeutic relevance,” Journal of Chemical Information and Modeling, vol. 47, no. 6, pp. 2316–2334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. P. A. Williams, J. Cosme, V. Sridhar, E. F. Johnson, and D. E. McRee, “Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity,” Molecular Cell, vol. 5, no. 1, pp. 121–131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. C. T. Supuran and A. Scozzafava, “Carbonic anhydrases as targets for medicinal chemistry,” Bioorganic & Medicinal Chemistry, vol. 15, no. 13, pp. 4336–4350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. J. L. Boyer, “Bile formation and secretion,” Comprehensive Physiology, vol. 3, no. 3, pp. 1035–1078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Chen, “TCM and infectious disease,” Acupuncture Today, vol. 12, no. 5, 2011, http://www.acupuncturetoday.com/mpacms/at/article.php?id=32393. View at Google Scholar
  126. A. E. Brady and L. E. Limbird, “G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction,” Cellular Signalling, vol. 14, no. 4, pp. 297–309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  127. W.-J. Bei, J. Guo, H.-Y. Wu, and Y. Cao, “Lipid-regulating effect of traditional Chinese medicine: mechanisms of actions,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 970635, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. H. K. Ghayee and R. J. Auchus, “Basic concepts and recent developments in human steroid hormone biosynthesis,” Reviews in Endocrine and Metabolic Disorders, vol. 8, no. 4, pp. 289–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. B. Zhu and H. Wang, Diagnostics of Traditional Chinese Medicine, Jessica Kingsley, London, UK, 2011.
  130. A. Bender, “Compound bioactivities go public,” Nature Chemical Biology, vol. 6, article 309, 2010. View at Publisher · View at Google Scholar
  131. K. M. Wu, J. G. Farrelly, R. Upton, and J. Chen, “Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development,” Phytomedicine, vol. 14, no. 4, pp. 273–279, 2007. View at Publisher · View at Google Scholar · View at Scopus